Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$418M |
| 2 |
AGN
Allergan plc
AGN
|
+$403M |
| 3 |
GGP
GGP Inc.
GGP
|
+$268M |
| 4 |
Starbucks
SBUX
|
+$204M |
| 5 |
American Airlines Group
AAL
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$769M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$597M |
| 3 |
Apple
AAPL
|
+$280M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$165M |
| 5 |
Johnson & Johnson
JNJ
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14% |
| 2 | Financials | 13.9% |
| 3 | Technology | 13.71% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Standard BioTools
LAB
$309M
| $16.9M | 0.01% |
402,133
+55,354
| +16% | +$2.19M |
|
1702
Gildan
GIL
$10.8B
| $16.9M | 0.01% |
573,190
-13,450
| -2% | -$393K |
|
1703
Vanguard Information Technology ETF
VGT
$147B
| $16.9M | 0.01% |
1,268,712
-28,760
| -2% | -$380K |
|
1704
Ethan Allen Interiors
ETD
$602M
| $16.9M | 0.01% |
610,091
+28,534
| +5% | +$812K |
|
|
CIM
1705
Chimera Investment
CIM
$996M
| $16.9M | 0.01% |
357,843
-61,284
| -15% | -$2.93M |
|
1706
Magna International
MGA
$18.8B
| $16.8M | 0.01% |
313,983
+13,867
| +5% | +$714K |
|
|
ARIA
1707
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $16.8M | 0.01% |
2,042,956
+30,322
| +2% | +$224K |
|
|
PIR
1708
DELISTED
Pier 1 Imports, Inc.
PIR
| $16.8M | 0.01% |
60,021
+2,342
| +4% | +$678K |
|
1709
Booz Allen Hamilton
BAH
$9.45B
| $16.8M | 0.01% |
579,545
+138,787
| +31% | +$4.04M |
|
1710
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
$2.53B
| $16.8M | 0.01% |
68,709,898
+701,709
| +1% | +$17.1M |
|
1711
Scansource
SCSC
$1.05B
| $16.7M | 0.01% |
411,798
+12,594
| +3% | +$477K |
|
|
ACOR
1712
DELISTED
Acorda Therapeutics
ACOR
| $16.7M | 0.01% |
4,183
+65
| +2% | +$298K |
|
1713
IMAX
IMAX
$2.77B
| $16.7M | 0.01% |
495,286
+27,072
| +6% | +$900K |
|
1714
WD-40
WDFC
$3.13B
| $16.7M | 0.01% |
188,071
+4,437
| +2% | +$373K |
|
|
DOC
1715
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $16.6M | 0.01% |
944,760
+338,746
| +56% | +$5.72M |
|
1716
REX American Resources
REX
$1.43B
| $16.6M | 0.01% |
1,640,322
+37,632
| +2% | +$362K |
|
|
CONE
1717
DELISTED
CyrusOne Inc Common Stock
CONE
| $16.6M | 0.01% |
532,425
-29,729
| -5% | -$878K |
|
1718
Equinor
EQNR
$97.2B
| $16.6M | 0.01% |
941,708
+60,308
| +7% | +$1.07M |
|
1719
Agios Pharmaceuticals
AGIO
$1.95B
| $16.6M | 0.01% |
175,635
+10,815
| +7% | +$1.21M |
|
1720
Pegasystems
PEGA
$5.44B
| $16.5M | 0.01% |
1,521,372
+16,316
| +1% | +$169K |
|
|
CLDT
1721
Chatham Lodging
CLDT
$580M
| $16.5M | 0.01% |
560,338
+98,498
| +21% | +$2.95M |
|
|
BF
1722
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
| $16.5M | 0.01% |
+165,622
| New | +$16.5M |
|
1723
PC Connection
CNXN
$2.04B
| $16.5M | ﹤0.01% |
630,624
+39,618
| +7% | +$973K |
|
|
CVSA
1724
Covista Inc
CVSA
$4.31B
| $16.4M | ﹤0.01% |
491,979
-4,498
| -0.9% | -$175K |
|
|
JRN
1725
DELISTED
JOURNAL COMMUNICATIONS INC CL-A
JRN
| $16.4M | ﹤0.01% |
1,106,296
-707,969
| -39% | -$8.26M |
|
Similar funds
Northern Trust's Q1 2015 Portfolio in Review
As of Q1 2015, Northern Trust held 4,454 positions worth $333B, up 0.39% from $331B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Northern Trust's Q1 2015 filing shows 185 new, 2,333 increased, 1,613 reduced and 120 closed positions. Its largest new stake was Qorvo: 2,554,147 shares worth $204M. The largest sale was Allergan Inc, an estimated $769M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- Northern Trust's largest Q1 2015 buy was Qorvo: 2,554,147 shares worth $204M.
- Northern Trust added most to Medtronic in Q1 2015, an estimated $418M increase.
- Northern Trust's biggest Q1 2015 reduction was Apple, cutting an estimated $280M.
- Northern Trust fully exited Allergan Inc in Q1 2015, selling an estimated $769M.
- Northern Trust's ten largest holdings make up 13% of its $333B portfolio in Q1 2015.
- Northern Trust opened 185 new positions and closed 120 in Q1 2015.
- Northern Trust's portfolio value rose 0.39% quarter-over-quarter to $333B.
Based on Northern Trust's 13F filing for Q1 2015, filed 14 May 2015.